North Immunology joins biotech reverse merger boom with Aethlon deal
Dive Brief: North Immunology, in the early stages of developing a potential competitor for the widely popular inflammatory disease drug…
Dive Brief: North Immunology, in the early stages of developing a potential competitor for the widely popular inflammatory disease drug…
As a Sanofi veteran, Frédéric Marrache is well aware of the innovations shaping immunology. His tenure there came as Dupixent…
When a biotech startup reveals a substantial round of funding, the announcement typically includes information about a pipeline, or at…